Covered recipient · General Payments record
ADAM C MULLAN
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$1,531.30
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $530.96 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $275.11 | 10 |
| Averitas Pharma Inc. | $117.87 | 2 |
| Abbott Laboratories | $60.64 | 2 |
| Merz Pharmaceuticals, LLC | $35.74 | 1 |
| Bioventus LLC | $25.68 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $15.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $32.23 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125305249 | CMS |
| Abbott Laboratories | $28.41 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125305251 | CMS |
| ABBVIE INC. | $5.63 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079785 | CMS |
| ABBVIE INC. | $1.84 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079787 | CMS |
| ABBVIE INC. | $30.54 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079789 | CMS |
| ABBVIE INC. | $34.40 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079791 | CMS |
| ABBVIE INC. | $99.38 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079793 | CMS |
| ABBVIE INC. | $2.77 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079795 | CMS |
| ABBVIE INC. | $1.91 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079797 | CMS |
| ABBVIE INC. | $32.21 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079799 | CMS |
| ABBVIE INC. | $33.22 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079801 | CMS |
| ABBVIE INC. | $33.21 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105079803 | CMS |
| Averitas Pharma Inc. | $14.75 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133438201 | CMS |
| Averitas Pharma Inc. | $103.12 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133438205 | CMS |
| Bioventus LLC | $25.68 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137445810 | CMS |
| Boston Scientific Corporation | $15.92 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092414786 | CMS |
| Merz Pharmaceuticals, LLC | $35.74 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137945988 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.